Evaxion significantly expands vaccine development collaboration with MSD
26 sept. 2024 07h30 HE
|
Evaxion Biotech
Agreement provides MSD with options to license Evaxion’s preclinical, AI-designed vaccine candidates EVX-B2 and EVX-B3Evaxion will host a conference call and webcast to discuss the agreement on...
Altamira Therapeutics Provides Business Update and First Half 2024 Financial Results
24 sept. 2024 08h01 HE
|
Altamira Therapeutics Ltd
Hamilton, Bermuda, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Company to host conference call today at 8.30 a.m. ETContinued progress within core activities in RNA delivery, supported by move into new...
Armlogi to Announce Fiscal Year 2024 Financial Results on Thursday, September 26
19 sept. 2024 08h00 HE
|
Armlogi Holding Corp
WALNUT, CA, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Armlogi Holding Corp. (“Armlogi” or the “Company”) (Nasdaq: BTOC), a U.S.-based warehousing and logistics service provider that offers a comprehensive...
Banco Santander Chile: Announces Third Quarter 2024 Analyst and Investor Webcast / Conference Call
11 sept. 2024 15h50 HE
|
Banco Santander Chile
SANTIAGO, Chile, Sept. 11, 2024 (GLOBE NEWSWIRE) -- You are cordially invited to participate in Banco Santander Chile's (NYSE: BSAC) conference call-webcast on Wednesday, October 30, 2024, at 11.00...
Retail Opportunity Investments Corp. Schedules Third Quarter Earnings Release and Conference Call
11 sept. 2024 09h00 HE
|
Retail Opportunity Investments Corp.
Retail Opportunity Investments Corp. Schedules Third Quarter Earnings Release and Conference Call
Agios to Present at the 2024 Cantor Global Healthcare Conference on September 18, 2024
05 sept. 2024 07h00 HE
|
Agios Pharmaceuticals, Inc.
Agios is scheduled to present at the 2024 Cantor Global Healthcare Conference on Wednesday, September 18, 2024, at 10:20 a.m. ET.
Pharming Group to participate in September investor conferences
04 sept. 2024 01h00 HE
|
Pharming Group N.V.
Leiden, the Netherlands, September 4, 2024: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming’s management will participate in the following investor...
Arbutus to Participate in Two Upcoming Investor Conferences
03 sept. 2024 07h30 HE
|
Arbutus Biopharma Corporation
WARMINSTER, Pa., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive...
CytoSorbents to Present at the H.C. Wainwright 26ᵗʰ Annual Global Investment Conference
27 août 2024 07h00 HE
|
CytoSorbents
PRINCETON, N.J., Aug. 27, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
Optinose to Present at the H.C. Wainwright 26th Annual Global Investment Conference
26 août 2024 09h00 HE
|
Optinose, Inc.
YARDLEY, Pa., Aug. 26, 2024 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced...